LRRK2-G2019S mutation is not associated with an increased cancer risk: A kin-cohort study

Movement Disorders

Volumn 29, Issue 10, 2014, Pages 1325-1326

  Allegra, Roberta ^a   Tunesi, Sara ^b   Cilia, Roberto ^a   Pezzoli, Gianni ^a   Goldwurm, Stefano ^a  

^a PARKINSON INSTITUTE   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; GLYCINE; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SERINE;

CANCER RISK; COHORT ANALYSIS; COLON CARCINOMA; DISEASE DURATION; FIRST DEGREE RELATIVE; FOLLOW UP; GENETIC SCREENING; HUMAN; INFLAMMATORY BOWEL DISEASE; INHERITANCE; LETTER; MEDICAL EXAMINATION; MUTATION; NORTH AFRICAN; PARKINSON DISEASE; PROSTATE CARCINOMA; STOMACH CANCER; TELEPHONE INTERVIEW; CASE CONTROL STUDY; FEMALE; GENETICS; MALE; NEOPLASM; RISK FACTOR; SIBLING;

CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GLYCINE; HUMANS; MALE; MUTATION; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; SERINE; SIBLINGS;

EID: 84908483784     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25969     Document Type: Letter

References (7)

1. Lewis PA, Alessi DR. Deciphering the function of leucine-rich repeat kinase 2 and targeting its dysfunction in disease. Biochem Soc Trans 2012;40:1039-1041.
2. Saunders-Pullman R, Barrett MJ, Stanley KM, et al. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease. Mov Disord 2010;25:2536-2541.
3. Inzelberg R, Cohen OS, Aharon-Peretz J, et al. The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers. Neurology 2012;78:781-786.
4. Ruiz-Martínez J, de la Riva P, Rodríguez-Oroz MC, et al. Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2. Mov Disord 2014;29:750-755.
5. Goldwurm S, Tunesi S, Tesei S, et al. Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease. Mov Disord 2011;26:2144-2145.
6. Cilia R, Siri C, Rusconi D, et al. LRRK2 mutations in Parkinson's Disease: confirmation of a gender effect in the Italian population. Parkinsonism Relat Disord 2014 Apr 25. [cited 14 July 2014]. Available from: http://dx.doi.org/10.1016/j.parkreldis.2014.04.016.
7. Strongosky AJ, Farrer M, Wszolek ZK. Are Parkinson disease patients protected from some but not all cancers? Neurology 2008; 71:1650.